Search

John D. Lee

Examiner (ID: 18653)

Most Active Art Unit
2501
Art Unit(s)
2501, 2874, 3621, 2504, 2507, 2606
Total Applications
2783
Issued Applications
2467
Pending Applications
118
Abandoned Applications
198

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7574130 [patent_doc_number] => 20110269786 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-03 [patent_title] => 'TREATMENT OF MAJOR ADVERSE CARDIAC EVENTS AND ACUTE CORONARY SYNDROME IN DIABETIC PATIENTS USING SECRETORY PHOSPHOLIPASE A2 (SPLA2) INHIBITOR OR SPLA2 INHIBITOR COMBINATION THERAPIES' [patent_app_type] => utility [patent_app_number] => 13/098261 [patent_app_country] => US [patent_app_date] => 2011-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 19575 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20110269786.pdf [firstpage_image] =>[orig_patent_app_number] => 13098261 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/098261
TREATMENT OF MAJOR ADVERSE CARDIAC EVENTS AND ACUTE CORONARY SYNDROME IN DIABETIC PATIENTS USING SECRETORY PHOSPHOLIPASE A2 (SPLA2) INHIBITOR OR SPLA2 INHIBITOR COMBINATION THERAPIES Apr 28, 2011 Abandoned
Array ( [id] => 6048666 [patent_doc_number] => 20110207742 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-25 [patent_title] => 'METHOD FOR REDUCTION, STABILIZATION AND PREVENTION OF RUPTURE OF LIPID RICH PLAQUE' [patent_app_type] => utility [patent_app_number] => 13/096477 [patent_app_country] => US [patent_app_date] => 2011-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10362 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20110207742.pdf [firstpage_image] =>[orig_patent_app_number] => 13096477 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/096477
METHOD FOR REDUCTION, STABILIZATION AND PREVENTION OF RUPTURE OF LIPID RICH PLAQUE Apr 27, 2011 Abandoned
Array ( [id] => 6064566 [patent_doc_number] => 20110201688 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-18 [patent_title] => 'N,N\'-DI-P-BROMOPHENYL GUANIDINE TREATMENT FOR STROKE AT DELAYED TIMEPOINTS' [patent_app_type] => utility [patent_app_number] => 13/090828 [patent_app_country] => US [patent_app_date] => 2011-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 5464 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0201/20110201688.pdf [firstpage_image] =>[orig_patent_app_number] => 13090828 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/090828
N,N'-DI-P-BROMOPHENYL GUANIDINE TREATMENT FOR STROKE AT DELAYED TIMEPOINTS Apr 19, 2011 Abandoned
Array ( [id] => 8056177 [patent_doc_number] => 20120077829 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-29 [patent_title] => 'PARENTERAL SOLUTIONS CONTAINING METOLAZONE' [patent_app_type] => utility [patent_app_number] => 13/076297 [patent_app_country] => US [patent_app_date] => 2011-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2367 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20120077829.pdf [firstpage_image] =>[orig_patent_app_number] => 13076297 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/076297
PARENTERAL SOLUTIONS CONTAINING METOLAZONE Mar 29, 2011 Abandoned
Array ( [id] => 8697843 [patent_doc_number] => 20130059851 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-07 [patent_title] => 'Methods of Diagnosing and Treating Cancer in Patients Having or Developing Resistance to a First Cancer Therapy' [patent_app_type] => utility [patent_app_number] => 13/583056 [patent_app_country] => US [patent_app_date] => 2011-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 26258 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13583056 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/583056
Methods of Diagnosing and Treating Cancer in Patients Having or Developing Resistance to a First Cancer Therapy Mar 8, 2011 Abandoned
Array ( [id] => 6048665 [patent_doc_number] => 20110207741 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-25 [patent_title] => 'Activation of the Renin-Angiotensin System (RAS) and Sudden Cardiac Death' [patent_app_type] => utility [patent_app_number] => 13/032629 [patent_app_country] => US [patent_app_date] => 2011-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 19045 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20110207741.pdf [firstpage_image] =>[orig_patent_app_number] => 13032629 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/032629
Activation of the Renin-Angiotensin System (RAS) and Sudden Cardiac Death Feb 21, 2011 Abandoned
Array ( [id] => 6214388 [patent_doc_number] => 20110136876 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-09 [patent_title] => 'Altering Pharmacokinetics of Pirfenidone Therapy' [patent_app_type] => utility [patent_app_number] => 13/028827 [patent_app_country] => US [patent_app_date] => 2011-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8861 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20110136876.pdf [firstpage_image] =>[orig_patent_app_number] => 13028827 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/028827
Altering Pharmacokinetics of Pirfenidone Therapy Feb 15, 2011 Abandoned
Array ( [id] => 8685108 [patent_doc_number] => 20130053392 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-28 [patent_title] => 'CARBONIC ANHYDRASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/578654 [patent_app_country] => US [patent_app_date] => 2011-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 14132 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13578654 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/578654
CARBONIC ANHYDRASE INHIBITORS Feb 13, 2011 Abandoned
Array ( [id] => 6213877 [patent_doc_number] => 20110136739 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-09 [patent_title] => 'Use of S1P Receptor Agonists in Heart Diseases' [patent_app_type] => utility [patent_app_number] => 13/023423 [patent_app_country] => US [patent_app_date] => 2011-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4820 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20110136739.pdf [firstpage_image] =>[orig_patent_app_number] => 13023423 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/023423
Use of S1P Receptor Agonists in Heart Diseases Feb 7, 2011 Abandoned
Array ( [id] => 6039503 [patent_doc_number] => 20110092552 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => 'Treatment and Prevention of Major Adverse Cardiovascular Events or Major Coronary Events by Administering Omega-3 Fatty Acids' [patent_app_type] => utility [patent_app_number] => 12/977111 [patent_app_country] => US [patent_app_date] => 2010-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6409 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20110092552.pdf [firstpage_image] =>[orig_patent_app_number] => 12977111 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/977111
Treatment and Prevention of Major Adverse Cardiovascular Events or Major Coronary Events by Administering Omega-3 Fatty Acids Dec 22, 2010 Abandoned
Array ( [id] => 8685066 [patent_doc_number] => 20130053350 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-28 [patent_title] => 'PPAR-SPARING THIAZOLIDINEDIONES AND COMBINATIONS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES' [patent_app_type] => utility [patent_app_number] => 13/515522 [patent_app_country] => US [patent_app_date] => 2010-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 27494 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13515522 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/515522
PPAR-SPARING THIAZOLIDINEDIONES AND COMBINATIONS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES Dec 14, 2010 Abandoned
Array ( [id] => 6118620 [patent_doc_number] => 20110076293 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-31 [patent_title] => 'TRIPTOLIDE DERIVATIVES FOR MODULATION OF APOPTOSIS AND IMMUNOSUPPRESSION' [patent_app_type] => utility [patent_app_number] => 12/961367 [patent_app_country] => US [patent_app_date] => 2010-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12581 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20110076293.pdf [firstpage_image] =>[orig_patent_app_number] => 12961367 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/961367
TRIPTOLIDE DERIVATIVES FOR MODULATION OF APOPTOSIS AND IMMUNOSUPPRESSION Dec 5, 2010 Abandoned
Array ( [id] => 5937743 [patent_doc_number] => 20110213027 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-01 [patent_title] => 'USE OF DRONEDARONE FOR THE PREPARATION OF A MEDICAMENT FOR USE IN THE PREVENTION OF CARDIOVASCULAR HOSPITALIZATION OR OF MORTALITY' [patent_app_type] => utility [patent_app_number] => 12/951494 [patent_app_country] => US [patent_app_date] => 2010-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13189 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20110213027.pdf [firstpage_image] =>[orig_patent_app_number] => 12951494 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/951494
USE OF DRONEDARONE FOR THE PREPARATION OF A MEDICAMENT FOR USE IN THE PREVENTION OF CARDIOVASCULAR HOSPITALIZATION OR OF MORTALITY Nov 21, 2010 Abandoned
Array ( [id] => 6016978 [patent_doc_number] => 20110224293 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-15 [patent_title] => 'USE OF DRONEDARONE FOR THE PREPARATION OF A MEDICAMENT FOR USE IN THE PREVENTION OF CARDIOVASCULAR HOSPITALIZATION OR OF MORTALITY' [patent_app_type] => utility [patent_app_number] => 12/951471 [patent_app_country] => US [patent_app_date] => 2010-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13195 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20110224293.pdf [firstpage_image] =>[orig_patent_app_number] => 12951471 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/951471
USE OF DRONEDARONE FOR THE PREPARATION OF A MEDICAMENT FOR USE IN THE PREVENTION OF CARDIOVASCULAR HOSPITALIZATION OR OF MORTALITY Nov 21, 2010 Abandoned
Array ( [id] => 8394247 [patent_doc_number] => 20120232087 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-13 [patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING SOLID TUMORS AND OTHER MALIGNANCIES' [patent_app_type] => utility [patent_app_number] => 13/509857 [patent_app_country] => US [patent_app_date] => 2010-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13904 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13509857 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/509857
METHODS AND COMPOSITIONS FOR TREATING SOLID TUMORS AND OTHER MALIGNANCIES Nov 16, 2010 Abandoned
Array ( [id] => 7501739 [patent_doc_number] => 20110263601 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'METHODS OF TREATING ULCERATIVE COLITIS' [patent_app_type] => utility [patent_app_number] => 12/911011 [patent_app_country] => US [patent_app_date] => 2010-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 32108 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20110263601.pdf [firstpage_image] =>[orig_patent_app_number] => 12911011 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/911011
METHODS OF TREATING ULCERATIVE COLITIS Oct 24, 2010 Abandoned
Array ( [id] => 5993506 [patent_doc_number] => 20110015159 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-20 [patent_title] => 'METHODS OF INHIBITING VASCULAR PERMEABILITY AND APOPTOSIS' [patent_app_type] => utility [patent_app_number] => 12/894783 [patent_app_country] => US [patent_app_date] => 2010-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8716 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20110015159.pdf [firstpage_image] =>[orig_patent_app_number] => 12894783 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/894783
Methods of inhibiting vascular permeability and apoptosis Sep 29, 2010 Issued
Array ( [id] => 6033189 [patent_doc_number] => 20110082114 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-07 [patent_title] => 'Methods of Treating Aneurysmal Dilatation, Blood Vessel Wall Weakness and Specifically Abdominal Aortic and Thoracic Aneurysm Using Matrix Metalloprotease-2 Inhibitors' [patent_app_type] => utility [patent_app_number] => 12/895073 [patent_app_country] => US [patent_app_date] => 2010-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16800 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20110082114.pdf [firstpage_image] =>[orig_patent_app_number] => 12895073 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/895073
Methods of Treating Aneurysmal Dilatation, Blood Vessel Wall Weakness and Specifically Abdominal Aortic and Thoracic Aneurysm Using Matrix Metalloprotease-2 Inhibitors Sep 29, 2010 Abandoned
Array ( [id] => 5993622 [patent_doc_number] => 20110015275 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-20 [patent_title] => 'Materials and Methods for Improving Alcohol Metabolism and Alleviating the Effects of Hangovers' [patent_app_type] => utility [patent_app_number] => 12/890890 [patent_app_country] => US [patent_app_date] => 2010-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3861 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20110015275.pdf [firstpage_image] =>[orig_patent_app_number] => 12890890 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/890890
Materials and methods for improving alcohol metabolism and alleviating the effects of hangovers Sep 26, 2010 Issued
Array ( [id] => 5993497 [patent_doc_number] => 20110015150 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-20 [patent_title] => 'METHODS OF ADMINISTERING COMPOSITIONS INCLUDING IRON' [patent_app_type] => utility [patent_app_number] => 12/891376 [patent_app_country] => US [patent_app_date] => 2010-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7970 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20110015150.pdf [firstpage_image] =>[orig_patent_app_number] => 12891376 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/891376
METHODS OF ADMINISTERING COMPOSITIONS INCLUDING IRON Sep 26, 2010 Abandoned
Menu